- Home
- RMTI vs FGEN Comparison
RMTI vs FGEN Comparison
Compare RMTI & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- FGEN
- Stock Information
- Founded
- RMTI 1994
- FGEN 1993
- Country
- RMTI United States
- FGEN United States
- Employees
- RMTI N/A
- FGEN N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- RMTI Health Care
- FGEN Health Care
- Exchange
- RMTI Nasdaq
- FGEN Nasdaq
- Market Cap
- RMTI 32.5M
- FGEN 33.5M
- IPO Year
- RMTI 1998
- FGEN 2014
- Fundamental
- Price
- RMTI $0.80
- FGEN $5.37
- Analyst Decision
- RMTI Strong Buy
- FGEN Strong Buy
- Analyst Count
- RMTI 2
- FGEN 1
- Target Price
- RMTI $4.00
- FGEN $250.00
- AVG Volume (30 Days)
- RMTI 201.7K
- FGEN 60.6K
- Earning Date
- RMTI 08-07-2025
- FGEN 08-05-2025
- Dividend Yield
- RMTI N/A
- FGEN N/A
- EPS Growth
- RMTI N/A
- FGEN N/A
- EPS
- RMTI N/A
- FGEN N/A
- Revenue
- RMTI $97,727,000.00
- FGEN $6,996,000.00
- Revenue This Year
- RMTI N/A
- FGEN N/A
- Revenue Next Year
- RMTI $11.16
- FGEN N/A
- P/E Ratio
- RMTI N/A
- FGEN N/A
- Revenue Growth
- RMTI 12.82
- FGEN N/A
- 52 Week Low
- RMTI $0.78
- FGEN $4.50
- 52 Week High
- RMTI $5.15
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- RMTI 32.97
- FGEN 36.45
- Support Level
- RMTI $0.80
- FGEN $4.85
- Resistance Level
- RMTI $0.87
- FGEN $5.73
- Average True Range (ATR)
- RMTI 0.05
- FGEN 0.51
- MACD
- RMTI -0.00
- FGEN -0.00
- Stochastic Oscillator
- RMTI 7.73
- FGEN 24.19
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.